Paris, April 3, 2019
Cabinet Dante - Information letter from 04/03/2019
Information letter of April 3, 2019: Launch of legal proceedings for the victims of Androcur.
First audiences on May 29, 2019.
Madam, sir,
the Méningiomes Association due to cyproterone acetate, aid to victims and taking into account other molecules (AMAVEA) contacted my office so that the victims of the drug Androcur and its generics are advised in possible amicable and judicial steps.
My office has been involved for many years in defense of victims of pharmaceutical laboratories, especially for the mediator, Dépakine, the H1N1 flu vaccine or the propécia.
I have already been contacted by several dozen people who consumed Androcur. It seems to me very important that the victims can unite their strength because in this type of case, union is strength in the face of an often powerful laboratory.
The procedures that I offer to people who enter my office are adapted to each file: indeed, each problem remains individual and it would be illusory to want to process the files collectively.
What are the steps to obtain compensation for its damages?
- It is necessary, prior to any approach, to obtain communication of the entire medical follow -up in connection with the consumption of Androcur.
My office is present to help you in these steps which can be difficult but which are necessary. - Once this medical file has been assembled, it is essential that my office, possibly helped by doctors who assist us, studies these documents to offer you the procedure which will be most suitable for your situation.
- In most cases, this procedure will take the form of an expertise summons to request the appointment of a legal expert independent of the parties and appointed by the judge.
This expertise procedure will take place in the presence of the Bayer laboratory but also of the National Office for the Compensation for Medical Accidents (ONIAM) as well as the National Medicines Safety Agency (ANSM) and will make it possible to assess all of your damages.
The elements in my possession on the drug Androcur and its side effects allow me to say that the Bayer laboratory had known for a very long time the risk of meningiomas and did not alert consumers.
The first expertise hearings will therefore be held on May 29, 2019 at the Bobigny tribunal de grande instance (located near Paris). I remind you that the victims do not need to move during these audiences.
I once again draw your attention to the need for victims to come together around an association which will allow them to be better heard both by the public authorities than by the judges.
I therefore invite you to contact the AMAVEA of which you will find the contact details on its website https://amavea.org .
I remain at your disposal for any further information:
- By email: cjo@dante-avocats.fr or gbq@dante-avocats.fr
- By phone on 01 43 22 44 53.
Do not hesitate to contact us for any difficulty relating to the constitution of your medical file or for any general question relating to these issues. You can also consult the website of my firm http://www.dante-avocats.fr .
Please receive, madam, sir, the expression of my sincere greetings.
Charles Joseph-Oudin,
Court lawyer
